Mergers and Acquisitions

Mergers and Acquisitions Articles

This newly combined company would target roughly €900 million of operating cost synergies to be achieved on a full year basis in 2019.
Dr Pepper Snapple has announced that it will invest $20 million to purchase a nearly 12% ownership stake in premium sport drink maker BA Sports Nutrition.
SFX Entertainment has had a dismal Friday, with shares down 20%. The company recently reported a loss for its second quarter, but the real issue hinges around an existing effort at a sale or merger.
Planar Systems announced Thursday morning that it entered into a definitive agreement to be acquired by a U.S. affiliate of Leyard Optoelectronic.
As Symantec reported its most recent quarterly results, it confirmed its plans to spin off its information management business.
Shenandoah Telecommunications reportedly is acquiring NTELOS Holdings, while Yodlee is being acquired by Envestnet. But are shareholders are getting enough?
Google will to be asking shareholders to trust management, albeit new management. Without much surprise, Google shares rose 5% or so in the after-hours session on this news.
Response Genetics has executed an asset purchase agreement with Cancer Genetics as a "stalking horse" bidder to potentially acquire all of the company's assets.
Baxalta has not been public as a standalone entity very long at all, when you consider that Shire is now interested in it.
Warren Buffett's Berkshire Hathaway announced this morning that it has reached a definitive agreement to acquire Precision Castparts in a transaction valued at about $37.2 billion.
courtesy of Precision Castparts Corp.The word on the Street is that Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) may spend $30 billion (or likely more) to acquire Precision Castparts...
ThinkstockInternational Business Machines Corp. (NYSE: IBM) announced a small acquisition of Merge Healthcare (NASDAQ: MRGE) this week. The firm Janney Capital Markets sees this close to the way 24/7...
Shots were fired again on the Horizon Pharma and DepoMed merger front. However it was DepoMed this time pushing back.
The world of mergers and acquisition can be rather strange. When you include private equity firms in the mix, deals can become even more strange.
Is it possible that activist investors now have just too much money under their management and are simply biting off more than they can chew?